ARCUTIS BIOTHERAPEUTICS
(NASDAQ: ARQT)

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

8.670

+0.360 (+4.33%)
Range 8.450 - 9.105   (7.75%)
Open 8.450
Previous Close 8.310
Bid Price 9.480
Bid Volume 8
Ask Price 9.750
Ask Volume 14
Volume 1,985,273
Value -
Remark
Delayed prices. Updated at 02 Nov 2024 04:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis